{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:23:10Z","timestamp":1767907390390,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":2942,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.curtheres.2005.08.012","type":"journal-article","created":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T11:07:21Z","timestamp":1128942441000},"page":"345-363","source":"Crossref","is-referenced-by-count":16,"title":["Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term"],"prefix":"10.1016","volume":"66","author":[{"given":"Werner","family":"Janssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Gatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Pfaffenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2005.08.012_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.44.2008.S1","article-title":"An evidencebased appraisal of reflux disease management-The Genval Workshop Report","volume":"44","author":"Dent","year":"1999","journal-title":"Gut."},{"key":"10.1016\/j.curtheres.2005.08.012_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2036.1999.00564.x","article-title":"On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebocontrolled randomized trial","volume":"13","author":"Lind","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2036.2001.00943.x","article-title":"Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: A controlled trial of \u2018on-demand\u2019 therapyfor 6 months","volume":"15","author":"Talley","year":"2001","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00042737-200208000-00008","article-title":"Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months","volume":"14","author":"Talley","year":"2002","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.curtheres.2005.08.012_bib5","first-page":"607","article-title":"On-demand therapy for Los Angeles Grade A and B reflux esophagitis: Esomeprazole versus omeprazole","volume":"102","author":"Kao","year":"2003","journal-title":"J Formos Med Assoc."},{"key":"10.1016\/j.curtheres.2005.08.012_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/00365520212499","article-title":"On-demand treatment in patients with oesophagitis and reflux symptoms: Comparison of lansoprazole and omeprazole","volume":"37","author":"Johnsson","year":"2002","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.curtheres.2005.08.012_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2004.02155.x","article-title":"Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negativegastro-oesophageal reflux patients: The COMMAND study","volume":"20","author":"Tsai","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"issue":"Suppl 6","key":"10.1016\/j.curtheres.2005.08.012_bib8","first-page":"A137","article-title":"Efficacy of lansoprazole on demand therapy in the treatment of non-erosive ref lux disease and functional ulcer-like dyspepsia","volume":"52","author":"Cooper","year":"2003","journal-title":"Gut."},{"key":"10.1016\/j.curtheres.2005.08.012_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/B:DDAS.0000034551.39324.c3","article-title":"On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: Effectiveness, health-related quality of life, and patient satisfaction","volume":"49","author":"Ponce","year":"2004","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.curtheres.2005.08.012_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2036.2004.01999.x","article-title":"Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive ref lux disease","volume":"20","author":"Bytzer","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2036.1998.00384.x","article-title":"On-demand treatment of gastro-oesophageal ref lux symptoms: A comparison of ranitidine 75 mg with cimetidine 200 mg or placebo","volume":"12","author":"Galmiche","year":"1998","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2036.1999.00575.x","article-title":"On demand therapy of reflux oesophagitis\u2014a prospective study of symptoms, patient satisfaction and quality of life","volume":"13","author":"Wilhelmsen","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2036.2004.02093.x","article-title":"Personal view: Rationale and proposed algorithms for symptombased proton pump inhibitor therapy for gastro-oesophageal reflux disease","volume":"20","author":"Bytzer","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib14","first-page":"463","article-title":"Factors influencing compliance in long-term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin","year":"1999","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.curtheres.2005.08.012_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1572-0241.2000.01759.x","article-title":"A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal ref lux disease","volume":"95","author":"Gerson","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.curtheres.2005.08.012_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2036.2004.01916.x","article-title":"Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastrooesophageal reflux symptoms in primary care","volume":"19","author":"Meineche-Schmidt","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2036.2003.01410.x","article-title":"Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis","volume":"17","author":"Metz","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00042737-200012040-00010","article-title":"Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease","volume":"12","author":"Plein","year":"2000","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.curtheres.2005.08.012_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1365-2036.1999.00651.x","article-title":"Maintenance therapy with pantoprazole 20 mg prevents relapse of ref lux oesophagitis","volume":"13","author":"Escourrou","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.curtheres.2005.08.012_bib20","unstructured":"Scholten T, Dekkers CP, Sch\u00fctze K, et al. On-demand therapy with pantoprazole20 mg as effective long-term management of reflux disease in patients with mild GERD: The ORION trial. Digestion. In press."},{"key":"10.1016\/j.curtheres.2005.08.012_bib21","unstructured":"Kaspari S, Kupcinskas L, Heinze H, et al. On-demand therapy with pantoprazole20 mg as effective long-term management of patients suffering from mild GERD. Ear J Gastroenterol Hepatol. In press."},{"key":"10.1016\/j.curtheres.2005.08.012_bib22","author":"Savary","year":"1977"},{"key":"10.1016\/j.curtheres.2005.08.012_bib23","first-page":"381","article-title":"Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy","volume":"24","author":"Siewert","year":"1986","journal-title":"Z Gastroenterol."},{"key":"10.1016\/j.curtheres.2005.08.012_bib24","series-title":"International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice[EMEA Web site]","author":"European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"10.1016\/j.curtheres.2005.08.012_bib25","year":"1989"},{"key":"10.1016\/j.curtheres.2005.08.012_bib26","series-title":"Nonparametric Statistical Methods","author":"Hollander","year":"1999"},{"issue":"Suppl 6","key":"10.1016\/j.curtheres.2005.08.012_bib27","first-page":"A178","article-title":"Efficacy and safety of pantoprazole used continuously or intermittently in patients with mild gastro-esophageal reflux disease","volume":"52","author":"Top","year":"2003","journal-title":"Gut."},{"issue":"Supp16","key":"10.1016\/j.curtheres.2005.08.012_bib28","first-page":"A128","article-title":"Efficacy of continued and \u2018on-demand\u2019 regimens of pantoprazole 20 mg in mild gastroesophageal reflux disease","volume":"52","author":"Lacevic","year":"2003","journal-title":"Gut."},{"issue":"Supp16","key":"10.1016\/j.curtheres.2005.08.012_bib29","first-page":"A130","article-title":"Esomeprazole continuous versus on-demand maintenance therapy in 1052 gastroesophageal reflux disease patients: Similar satisfaction but superior quality of life for once daily treatment","volume":"52","author":"Engels","year":"2003","journal-title":"Gut."}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X05000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:50:16Z","timestamp":1548114616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X05000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0011393X05000834"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2005.08.012","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}